AATec Medical GmbH is a biotechnology company developing a product platform based on recombinant alpha-1 antitrypsin.
The platform is intended for treatment of inflammatory diseases, virus infections, and rare diseases.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Its first product candidate is a novel AAT formulation for inhalation, intended to treat emerging inflammatory diseases of the lung and respiratory virus infections.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 16, 2026, September 19, 2026 and September 20, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.